Mckean Research Institute

Exploring Our Research Horizons

Diverse Clinical Trials Driving Innovation Across Key Health Areas

At McKean Research Institute, we specialize in a diverse range of clinical trials to advance medical science and improve patient care. Our focus includes:

  • Oncology: Innovating cancer treatments to enhance survival rates and quality of life.
  • Cardiology: Exploring new therapies for heart disease and cardiovascular health.
  • Neurology: Pioneering research in neurological disorders to develop effective treatments.
  • Immunology: Investigating immune system disorders to find new solutions for autoimmune diseases.
  • Pediatrics: Conducting studies to advance child health with safe and effective treatments.
  • Rare Diseases: Focusing on rare and orphan diseases to provide new options for patients with limited alternatives.

Each of these areas is addressed with a commitment to rigorous research and patient-centered care, ensuring that our trials contribute meaningfully to medical progress.

Diverse Research Areas

Innovating Treatments in Key Health Areas

Gastroenterology Trials

Investigating new treatments for digestive system disorders to improve gastrointestinal health and patient quality of life.

Endocrinology Research

Exploring innovative therapies for hormone-related conditions, such as diabetes and thyroid disorders, to enhance endocrine health.

Respiratory Studies

Advancing treatments for respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD) to improve breathing and lung function.

Dermatology Trials

Researching new therapies for skin conditions, from common ailments like eczema to complex disorders such as psoriasis.

Rheumatology Research

Focusing on the development of treatments for autoimmune and inflammatory diseases, including rheumatoid arthritis and lupus.

Infectious Disease Studies

Conducting trials to find effective treatments and vaccines for infectious diseases, aiming to combat global health threats and enhance public health.

Start Your health journey

Text “TRIAL” to 18556922182 signup for recurring marketing alerts. Message and data rates may apply. By subscribing above, you confirm you are authorized to add the telephone number and hereby give consent to receive SMS/text messages from you at the telephone number. You understand that your consent is not required as a condition to purchase products or services. When you subscribe to “Mckean Research Institute” program by Afgar. Message & data rates may apply. You also accept our Terms and Conditions and our Privacy Policy. Msg freq may vary. You may revoke future alerts and messages via the online portal or by texting “STOP” to 18556922182 opt out. For help text “HELP” to 18556922182. T-Mobile is not liable for delayed or undelivered messages


    Telehealth Services